J&J ordered to pay $417 mln in trial over talc cancer risks
August 21, 2017 at 13:51 PM EDT
Aug 21 (Reuters) - Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.
